Antibiotic Sensitivity Pattern of Serratia Species from Clinical Samples at a Tertiary Care Hospital in Rawalpindi
DOI:
https://doi.org/10.51985/JBUMDC202216Abstract
Objective. To determine the antibiotic resistance profile of Serratia spp isolated from various clinical specimens.
Study Design and Settings: A descriptive cross-sectional study on antibiotic resistance profile of Serratia spp isolated
from various clinical specimens was carried out in the Department of Microbiology, Armed Forces Institute of Pathology,
Rawalpindi, from 1st July 2017 to 30th June 2021.
Methodology: 464 clinical specimens yielding growth of Serratia spp were included in the study. Serratia spp were
identified by using Standard Microbiological procedures. Modified Kirby Bauer disc diffusion method was used for
Antibiotic Susceptibility testing. The clinical data was analyzed prospectively from July 2017 to June 2021 for a period
of 4 years. The spectrum of diseases caused by Serratia spp along with resistance profiles were analyzed. . Data obtained
was analysed using SPSS 24.
Results: High yield of this bug was obtained from pus and tissue specimens 150 (32%).130(28%) isolates were retrieved
from blood cultures, whereas respiratory specimens contributed to 89(19 %) isolates of Serratia spp. According to the
antimicrobial susceptibility pattern, 154 (33.3%) isolates were sensitive to Meropenem, 150(32.2%) were susceptible to
Doxycycline and 118 (25.5%) to Amikacin, making them the preferred antibiotics to be used in our setup.
Conclusion: Serratia marcescens isolates are increasingly resistant to antibiotics. Clinical isolates of Serratia exhibited
highest resistance to Ciprofloxacin, Ceftriaxone, Gentamicin and Piperacillin/tazobactam.
References
Campos-Cortés CL, González GM, Andrade A, TreviñoRangel RD. Epidemiological Panorama of Serratia marcescens:
Antimicrobial Resistance and Virulence Factors. Medicina
Universitaria. 2018;20(2):91-8. http://dx.doi.org/%10. 24875
/RMU.M18000014
Herra C, Falkiner FR. Serratia marcescens. Antimicrobe
Microbes. Available at: http://www. antimicrobe. org/b26.
asp. Accessed July. 2017;27.
Kim SB, Jeon YD, Kim JH, Kim JK, Ann HW, Choi H, Kim
MH, Song JE, Ahn JY, Jeong SJ, Ku NS. Risk factors for
mortality in patients with Serratia marcescens bacteremia.
Yonsei medical journal. 2015 ;56(2):348-54. https:// doi.org/
3349/ymj.2015.56.2.348
Martineau C, Li X, Lalancette C, Perreault T, Fournier E,
Tremblay J, Gonzales M, Yergeau É, Quach C. Serratia
marcescens outbreak in a neonatal intensive care unit: new
insights from next-generation sequencing applications. Journal
of clinical microbiology. 2018 Sep 1;56(9): e00235-18. DOI:
https:// doi.org/10.1128/JCM.00235-18
Francés-Cuesta C, Sánchez-Hellín V, Gomila B, GonzálezCandelas F. Is there a widespread clone of Serratia marcescens
producing outbreaks worldwide? Journal of Hospital Infection.
; 108:7-14. https://doi.org/10.1016 /j.jhin.2020. 10.029
Sana F, Satti L, Zaman G, Gardezi A, Imtiaz A, Khadim T.
LAB RESEARCH. doi: 10.5455/JPMA.298528
Marin L, Rowan R, Mantilla A, Olupona B, MacIntyre A.
Lower-extremity infections caused by Serratia marcescens:
a report of three cases and a literature review. Journal of the
American Podiatric Medical Association. 2017;107(3):231-
https://doi.org/10.7547/15-180
Khanna A, Khanna M, Aggarwal A. Serratia marcescens-a
rare opportunistic nosocomial pathogen and measures to limit
its spread in hospitalized patients. Journal of clinical and
diagnostic research: JCDR. 2013;7(2):243. https:// dx.doi.org/
7860%2FJCDR%2F2013%2F5010.2737
Stock I, Grueger T, Wiedemann B. Natural antibiotic
susceptibility of strains of Serratia marcescens and the S.
liquefaciens complex: S. liquefaciens sensu stricto, S.
proteamaculans and S. grimesii. International journal of
antimicrobial agents. 2003;22(1):35-47. https://doi.org/ 10.1016
/S0924-8579(02)00163-2
Cristina ML, Sartini M, Spagnolo AM. Serratia marcescens
infections in neonatal intensive care units (NICUs).
International journal of environmental research and public
health. 2019;16(4):610. https://doi.org/10.3390 /ijerph160
Clinical and Laboratory Standards Institute. CLSI M100 30th
Edition. Vol. 30th, Journal of Services Marketing. 2020
Merkier AK, Rodríguez MC, Togneri A, Brengi S, Osuna C,
Pichel M, Cassini MH, Serratia marcescens Argentinean
Collaborative Group, Centrón D. Outbreak of a cluster with
epidemic behavior due to Serratia marcescens after colistin
administration in a hospital setting. Journal of clinical
microbiology. 2013;51(7):2295-302. https://doi.org/10.1128/
JCM.03280-12
Saralegui C, Ponce-Alonso M, Pérez-Viso B, Moles Alegre
L, Escribano E, Lázaro-Perona F, Lanza VF, de Pipaón MS,
Rodríguez JM, Baquero F, Del Campo R. Genomics of Serratia
marcescens isolates causing outbreaks in the same pediatric
unit 47 years apart: position in an updated phylogeny of the
species. Frontiers in microbiology. 2020; 11:451. https://doi.org/
3389/fmicb.2020.00451
Morillo Á, González V, Aguayo J, Carreño C, Torres MJ,
Jarana D, Artacho MJ, Jiménez F, Conde M, Aznar J. A sixmonth Serratia marcescens outbreak in a neonatal intensive
care unit. Enfermedadesinfecciosas y microbiologiaclinica.
;34(10):645-51. https://doi.org/10.1016 /j.eimc. 2016.
006
Ferreira RL, Rezende GS, Damas MS, Oliveira-Silva M,
Pitondo-Silva A, Brito MC, Leonardecz E, Góes FR,
Campanini EB, Malavazi I, da Cunha AF. Characterization
of KPC-Producing Serratia marcescens in an Intensive Care
Unit of a Brazilian Tertiary Hospital. Frontiers in microbiology.
; 11:956. https://doi.org/10.3389 /fmicb.2020. 00956
O'Horo J, Mahler S, Gardner B, Berbari E. Serratia and
Surgical Site Infections: Risk factors and Epidemiology.
InOpen Forum Infectious Diseases 2017 Oct (Vol. 4).
Laupland KB, Parkins MD, Gregson DB, Church DL, Ross
T, Pitout JD. Population-based laboratory surveillance for
Serratia species isolates in a large Canadian health region.
European Journal of Clinical Microbiology & Infectious
Diseases. 2008;27(2):89-95.
Ulu-Kilic AY, Parkan O, Ersoy S, Koc D, Percin DU, Onal
O, Metan GÖ, Alp E. Outbreak of postoperative empyema
caused by Serratia marcescens in a thoracic surgery unit.
Journal of Hospital Infection. 2013;85(3):226-9. https://
doi.org/10.1016/j.jhin.2013.07.008
Kim EJ, Park WB, Yoon JK, Cho WS, Kim SJ, Oh YR, Jun
KI, Kang CK, Choe PG, Kim JI, Choi EH. Outbreak
investigation of Serratia marcescens neurosurgical site
infections associated with a contaminated shaving razors.
Antimicrobial Resistance & Infection Control. 2020;9:1-7.
https://doi.org/10.1186/s13756-020-00725-6
Cristina ML, Sartini M, Spagnolo AM. Serratia marcescens
infections in neonatal intensive care units (NICUs).
International journal of environmental research and public
health. 2019;16(4):610. https://doi.org/ 10.3390/
ijerph16040610
Simsek M. Determination of the antibiotic resistance rates of
Serratia marcescens isolates obtained from various clinical
specimens. Nigerian journal of clinical practice. 2019 Feb
;22(1)
Hayashi W, Yoshida S, Izumi K, Koide S, Soga E, Takizawa
S, Arakawa Y, Nagano Y, Nagano N. Genomic characterisation
and epidemiology of nosocomial Serratia marcescens isolates
resistant to ceftazidime and their plasmids mediating rare
blaTEM-61. Journal of Global Antimicrobial Resistance. 2021
Jun 1; 25:124-31. https://doi.org/10.1016/j.jgar.2021.03.010
Xu Q, Fu Y, Zhao F, Jiang Y, Yu Y. Molecular characterization
of carbapenem-resistant Serratia marcescens Clinical isolates
in a tertiary hospital in Hangzhou, China. Infection and drug
resistance. 2020; 13:999. https://dx.doi.org/10.2147%2 FIDR.
S243197
Liou BH, Duh RW, Lin YT, Lauderdale TL, Fung CP; Taiwan
Surveillance of Antimicrobial Resistance (TSAR) Hospitals.
A multicenter surveillance of antimicrobial resistance in
Serratia marcescens in Taiwan. J Microbiol Immunol Infect.
;47(5):387-93. doi: 10.1016/j.jmii.2013.04.003. Epub
Jun 14. PMID: 23751769; PMCID: PMC7105062.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rafia Irfan, Iqra Sadiq, Amna Amer, Irfan Ali Mirza, Faisal Hanif, Wajid Hussain
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0 
